These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15638384)

  • 1. Plasma VEGF-A and its soluble receptor R1 correlate with the clinical stage of colorectal cancer.
    Myśliwiec P; Piotrowski Z; Zalewski B; Kukliński A; Pawlak K
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():85-7. PubMed ID: 15638384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T; Okada N; Nakada H; Yokoyama M; Miyazaki T; Ishibashi K; Ishida H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1841-4. PubMed ID: 17212123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
    Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients.
    Famulski W; Sulkowska M; Wincewicz A; Kedra B; Pawlak K; Zalewski B; Sulkowski S; Koda M; Baltaziak M
    Neoplasma; 2006; 53(1):43-8. PubMed ID: 16416012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
    Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
    Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of postoperative serum vascular endothelial growth factor (VEGF)--can it be used to predict curative resections in colorectal cancer?
    Kumar H; Heer K; Duthie GS; Monson JR
    Anticancer Res; 2002; 22(6B):3717-22. PubMed ID: 12552982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum erythropoietin and angiogenetic factors in human colorectal cancer.
    Chabowska A; Sulkowska M; Wincewicz A; Chabowski A; Mysliwiec M; Pawlak K; Koda M; Kedra B; Sulkowski S
    Prague Med Rep; 2007; 108(4):348-57. PubMed ID: 18780647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion.
    Abe A; Fukui H; Fujii S; Fujita M; Mukawa K; Ichikawa K; Tomita S; Ono Y; Imai Y; Imura J; Kubota K; Fujimori T
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1071-7. PubMed ID: 17608853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
    Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
    Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
    Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
    Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
    Roumen RM; Slooter GD; Croiset van Uchelen FA; Huib LV
    Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
    Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
    Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
    Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
    Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.